3-methyl-1-(pyridin-4-ylmethyl)-1H-pyrazol-5-amine | 30154-18-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-methyl-1-(pyridin-4-ylmethyl)-1H-pyrazol-5-amine
• 英文别名: 5-methyl-2-pyridin-4-ylmethyl-2H-pyrazol-3-ylamine；5-Methyl-2-pyridin-4-ylmethyl-2H-pyrazol-3-ylamine；5-methyl-2-(pyridin-4-ylmethyl)pyrazol-3-amine
• CAS: 30154-18-8
• 化学式: C₁₀H₁₂N₄
• 分子量: 188.232
• InChiKey: JVANFUCPPCNEMF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  56.7
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  3-methyl-1-(pyridin-4-ylmethyl)-1H-pyrazol-5-amine 在 三氯氧磷 作用下， 以 乙醇 为溶剂， 生成 ethyl 4-chloro-3-methyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
  参考文献：
  名称：

  [EN] PYRAZOLOPYRIMIDINES AS INHIBITORS OF GLUCOCORTICOID RECEPTOR TRANSLOCATION
  [FR] PYRAZOLOPYRIMIDINES UTILISÉES EN TANT QU'INHIBITEURS DE LA TRANSLOCATION DU RÉCEPTEUR DES GLUCOCORTICOÏDES

  摘要：

  公开号：

  WO2016123392A3
• 作为产物：
  描述：

  (tert-butoxy)-N-[(4-pyridylmethyl)amino]carboxamide 在 盐酸 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 生成 3-methyl-1-(pyridin-4-ylmethyl)-1H-pyrazol-5-amine
  参考文献：
  名称：

  [EN] PYRAZOLOPYRIMIDINES AS INHIBITORS OF GLUCOCORTICOID RECEPTOR TRANSLOCATION
  [FR] PYRAZOLOPYRIMIDINES UTILISÉES EN TANT QU'INHIBITEURS DE LA TRANSLOCATION DU RÉCEPTEUR DES GLUCOCORTICOÏDES

  摘要：

  公开号：

  WO2016123392A3

文献信息

• Noncatalytic Electrophilic Oxyalkylation of 3-Aminopyrazoles with 2-(Trifluoroacetyl)-1,3-azoles
  作者：Pavel Mykhailiuk、Pavel Khodakovskiy、Dmitriy Volochnyuk、Andrey Tolmachev

  DOI：10.1055/s-0029-1218657

  日期：2010.4

  2-(Trifluoroacetyl)-1,3-azoles reacted with 3-aminopyrazoles to give the corresponding trifluoromethyl-substituted alcohols. The conditions required for the reaction and the yields of the products were highly dependent on the electronic nature of the both the 1,3-azole and the 3-aminopyrazole units.

  2-(三氟乙酰基)-1,3-唑与3-氨基吡唑反应，生成相应的三氟甲基取代醇。反应所需的条件和产物的收率在很大程度上取决于1,3-唑和3-氨基吡唑单元的电子性质。
• Inhibitors of glucocorticoid receptor translocation
  申请人：Sanford Burnham Prebys Medical Discovery Institute

  公开号：US10272074B2

  公开（公告）日：2019-04-30

  Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of Glucocorticoid Receptor (GR) translocation. Furthermore, the subject compounds and compositions are useful for the treatment of diseases involved in the hypothalamic-pituitary-adrenal (HPA) axis.

  本文提供的是包含所述化合物的化合物和药物组合物。所述化合物和组合物可用作糖皮质激素受体（GR）转运的调节剂。此外，所述化合物和组合物还可用于治疗涉及下丘脑-垂体-肾上腺（HPA）轴的疾病。
• Discovery and Characterization of 1<i>H</i>-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators
  作者：Joshua M. Wieting、Anish K. Vadukoot、Swagat Sharma、Kristopher K. Abney、Thomas M. Bridges、J. Scott Daniels、Ryan D. Morrison、Kevin Wickman、C. David Weaver、Corey R. Hopkins

  DOI：10.1021/acschemneuro.7b00217

  日期：2017.9.20

  The G protein-gated inwardly-rectifying potassium channels (GIRK, KO) are a family of inward-rectifying potassium channels, and there is significant evidence supporting the roles of GIRKs in a number of physiological processes and as potential targets for numerous indications. Previously reported urea containing molecules as GIRK1/2 preferring activators have had significant pharmacokinetic (PK) liabilities. Here we report a novel series of 1H-pyrazolo-5yl-2-phenylacetamides in an effort to improve upon the PK properties. This series of compounds display nanomolar potency as GIRK1/2 activators with improved brain distribution (rodent K-p > 0.6).
• Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation
  申请人：Sanford-Burnham Medical Research Institute

  公开号：US20180207140A1

  公开（公告）日：2018-07-26

  Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of Glucocorticoid Receptor (GR) translocation. Furthermore, the subject compounds and compositions are useful for the treatment of diseases involved in the hypothalamic-pituitary-adrenal (HPA) axis.
• [EN] PYRAZOLOPYRIMIDINES AS INHIBITORS OF GLUCOCORTICOID RECEPTOR TRANSLOCATION<br/>[FR] PYRAZOLOPYRIMIDINES UTILISÉES EN TANT QU'INHIBITEURS DE LA TRANSLOCATION DU RÉCEPTEUR DES GLUCOCORTICOÏDES
  申请人：SANFORD-BURNHAM MEDICAL RES INST

  公开号：WO2016123392A3

  公开（公告）日：2016-10-27